DCM
NPCE icon

Driehaus Capital Management’s Neuropace NPCE Stock Holding History

Driehaus Capital Management’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.1M Sell
1,451,611
-59,678
-4% -$895K 0.14% 209
2025
Q4 		$23.3M Buy
1,511,289
+571,770
+61% +$7.65M 0.16% 185
2025
Q3 		$9.69M Sell
939,519
-65,839
-7% -$621K 0.07% 282
2025
Q2 		$11.2M Buy
1,005,358
+201,918
+25% +$2.52M 0.09% 242
2025
Q1 		$9.87M Buy
+803,440
New +$10.1M 0.1% 249

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Driehaus Capital Management's NPCE Position: Q1 2026 in Review

Driehaus Capital Management reduced its Neuropace (NPCE) stake by 3.9% in Q1 2026, selling an estimated $895K and leaving 1,451,611 shares worth $19.1M. The position accounts for 0.14% of the portfolio, ranked #209.

Driehaus Capital Management first reported a position in NPCE in Q1 2025 and has held it in 5 quarters since. The position peaked at $23.3M in Q4 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Driehaus Capital Management held 1,451,611 shares of Neuropace worth $19.1M as of Q1 2026.
  • Driehaus Capital Management sold 59,678 Neuropace shares in Q1 2026, an estimated $895K.
  • Neuropace made up 0.14% of Driehaus Capital Management's portfolio in Q1 2026, its #209 holding.
  • Driehaus Capital Management first reported a position in Neuropace in Q1 2025 and has held it in 5 quarters since.
  • Driehaus Capital Management's Neuropace position peaked at $23.3M in Q4 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.